Semeiotica Biofisica Quantistica. Il Nuovo Rinascimento della Medicina. www.sisbq.org

Non ho ancora letto sui mass-media italiani nessun riferimento su quanto  si legge su The Guardian, di cui ecco l’Incipit:

Breast cancer screening programmes have yet to show a reduction in the number of women who die from the disease, researchers say. A study suggests there is no evidence that screening women for breast cancer has an effect on mortality”.

Subito dopo una desolante notizia:

“In response to the controversy, the Department of Health commissioned a review into the risks and benefits in 2011. The independent panel concluded there was a 20% relative reduction in mortality from breast cancer in women invited to screening. But the latest research, published in the Journal of the Royal Society of Medicine, contests the findings “.

Ma alla fine, Pilato vince nell’Era dei Lumi Spenti:

“The most in-depth study of breast screening to date remains the recent independent breast screening review, which comprehensively looked at all available evidence. It concluded that screening does save lives by helping to detect breast cancers earlier.

“The quicker women are diagnosed the better their treatment options so we encourage all women to continue to attend screening when invited to do so”.

Come vedete la Scienza non dimostra assolutamente nulla, come afferma G. Bateson nel suo ormai classico “Nature and Mind”.

Di seguito il mio commento-accusa:

http://www.guardian.co.uk/society/2013/jun/11/breast-cancer-screening-no-evidence?commentpage=1
Stagnaro 11 June 2013 3:33pm
There is a general agreement that CVD, T2 DM, and Cancer, including breast cancer, are today’s growing epidemics. Unfortunately, the so-called Authorities of all NHSs do not say that Constitution-Dependent, Inherited Real Risks do really exist, bedside recognized, i.e., with a stethoscope, from birth, and removed by Quantum Therapy: References on request.
Un sola critica allo screening, a cui attendo una chiara, univoca risposta da parte dei massimi oncologi e senologi: “Che senso ha consigliare lo screening del cancro della mammella a donne senza il Terreno Oncologico e a quelle  positive per il Terrreno Oncologico MA negative per il Reale Rischio Congenito di cancro del seno?
Sergio Stagnaro and Simone Caramel (2013).  BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention.  Front. Genet. | doi: 10.3389/fgene.2013.00039.  http://www.frontiersin.org/Cancer_Genetics/10.3389/fgene.2013.00039/full [MEDLINE]

Lascia un commento

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione / Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione / Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione / Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione / Modifica )

Connessione a %s...

Tag Cloud

%d blogger cliccano Mi Piace per questo: